TherapeuticsMD, Inc. - FORM 8-K - EX-16.1 - LETTER TO THE SEC FROM KBL, LLP - December 22, 2010

Attached files

file filename
8-K - FORM 8-K - TherapeuticsMD, Inc.d8k.htm
EX-10.01 - NOTE PURCHASE AGREEMENT - TherapeuticsMD, Inc.dex1001.htm
EX-10.07 - ASSIGNMENT OF IP SECURITY - TherapeuticsMD, Inc.dex1007.htm
EX-10.02 - SECURED PROMISORY NOTE - TherapeuticsMD, Inc.dex1002.htm
EX-10.06 - GUARANTY AGREEMENT - TherapeuticsMD, Inc.dex1006.htm
EX-10.04 - SECURITY AGREEMENT - TherapeuticsMD, Inc.dex1004.htm
EX-10.03 - STOCK PLEDGE AND ESCROW AGREEMENT - TherapeuticsMD, Inc.dex1003.htm
EX-10.05 - GUARANTY SECURITY AGREEMENT - TherapeuticsMD, Inc.dex1005.htm

Exhibit 16.1

December 20, 2010

Securities and Exchange Commission

Washington, D.C. 20549

Commissioners:

We have read AMHN Inc. statements included under Item 4.01 of its Form 8-K filed on or about December 20, 2010, and we agree with such statements concerning our firm.

Sincerely,

 

/s/ KBL, LLP
KBL, LLP

TherapeuticsMD, Inc. Reports

Also read